TheraMAB LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for TheraMAB LLC.The latest application filed is for "compositions and methods for safe and effective immunotherapy".

Company Profile

1.8.8

TheraMAB LLC - Moscow RU
TheraMAB LLC. - Moscow RU
TheraMAB LLC. -
TheraMAB LLC - RU RU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Safe And Effective Immunotherapy App 20170198044 - MATSKEVICH; Alexey ; et al.	2017-07-13
Use Of An Active Substance Binding To Cd28 For Producing A Pharmaceutical Composition For The Treatment Of B-cll App 20160017039 - Hanke; Thomas	2016-01-21
Use Of A Cd28 Binding Pharmaceutical Substance For Making A Pharmaceutical Composition With Dose-dependent Effect App 20150376278 - Hanke; Thomas ; et al.	2015-12-31
Use of an active substance binding to CD28 for producing a pharmaceutical composition for activating and expanding T cells Grant 9,119,840 - Hanke September 1, 2	2015-09-01
Use Of Cd28-specific Monoclonal Antibodies For Producing A Pharmaceutical Composition For Treating Virus Infections App 20150150968 - Huenig; Thomas	2015-06-04
Superagonistic anti-CD28 antibodies Grant 8,709,414 - Hanke , et al. April 29, 2	2014-04-29
Use Of A Cd28 Binding Substance For Making A Pharmaceutical Composition App 20130266577 - Hunig; Thomas	2013-10-10
Use of a CD28 binding substance for making a pharmaceutical composition Grant 8,389,016 - Hunig March 5, 2	2013-03-05
Human CD28 specific monoclonal antibodies for antigen-nonspecific activation of T-lymphocytes Grant 8,334,102 - Hunig December 18, 2	2012-12-18
Use Of A Cd258 Binding Pharmaceutical Substrance For Making A Pharmaceutical Composition With Dose-dependent Effect App 20120219553 - Hanke; Thomas ; et al.	2012-08-30
Superagonistic Anti-CD28 Antibodies App 20120082683 - Hanke; Thomas ; et al.	2012-04-05
Superagonistic anti-CD28 antibodies Grant 8,034,585 - Hanke , et al. October 11, 2	2011-10-11
Superagonistic Anti-CD28 Antibodies App 20110189735 - Hanke; Thomas ; et al.	2011-08-04
Superagonistic anti-CD28 antibodies Grant 7,939,638 - Hanke , et al. May 10, 2	2011-05-10
Microparticle with cd28-specific monoclonal antibodies Grant 7,868,143 - Hunig January 11, 2	2011-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.